Mirtazapine Tablets

utilized to manage major depressive disorder to alleviate persistent low mood and emotional instability.

Strengths: 7.5 · 15 · 30mg

Medicine details

Alternative names

Zispin; Zispin SolTab

Therapeutic class

Tetracyclic Antidepressant

Pharmacological class

Tetracyclic Antidepressant

Known off-label uses

generalized anxiety disorder

Contraindications

hypersensitivity to mirtazapine; concurrent use of monoamine oxidase inhibitors

Minor side effects

drowsiness; sedation; dry mouth; increased appetite; weight gain

Moderate side effects

dizziness; lethargy; oedema; arthralgia

Dosage forms

Tablet

Administration route

Oral use

Prescription status

POM

Manufacturer

Organon Pharma

Onset Time

1–2 weeks

Duration

indefinite

Storage instructions

Store in original packaging below 30°C.

Drug interactions

alcohol; monoamine oxidase inhibitors; benzodiazepines

Age restrictions

Not recommended for children and adolescents under 18 years.

Precautions and warnings

may impair ability to drive or operate machinery; monitor for changes in mood or behaviour

Serious side effects

serotonin syndrome — requires immediate medical attention; severe neutropenia — requires immediate medical attention; convulsions — requires immediate medical attention

Patient summary

utilized to manage major depressive disorder to alleviate persistent low mood and emotional instability.

Mechanism of action

Mirtazapine works by increasing the release of norepinephrine and serotonin in the central nervous system. It acts as an antagonist at presynaptic alpha-2 adrenergic receptors, which enhances neurotransmitter signalling, helping to regulate mood and restore emotional balance in patients with depression.

Pregnancy and breastfeeding

Pregnancy: Use only if clearly necessary after medical consultation. Breastfeeding: Discuss with your doctor as transfer into breast milk is possible.

Mirtazapine Tablets

utilized to manage major depressive disorder to alleviate persistent low mood and emotional instability.

Editorial Notes

  • Active ingredient(s): Mirtazapine
  • Listed indication(s): Major Depressive Disorder

Usually available as

  • 180 tablets - 7.5 mg1199-7-5-mg-14187
  • 180 tablets - 15 mg1199-15-mg-14192
  • 90 tablets - 30 mg1199-30-mg-14195